Magdalena Cichewicz, PhD, on Improving AAV Gene Therapy With Synthetic Promoters
The scientist II at Senti Biosciences discussed the potential of synthetic promoters to improve target specificity in AAV vector-based gene therapies in retinal diseases and beyond.